Search Results - "Kato, Itaru"

Refine Results
  1. 1

    Development of dual-targeted CAR T-cell therapy by Kato, Itaru

    Published in Rinshō ketsueki (2024)
    “…Chimeric antigen receptor T-cell therapy (CAR-T-cell therapy) has revolutionized the treatment of relapsed and refractory hematological malignancies. Targeting…”
    Get more information
    Journal Article
  2. 2

    Flow Cytometric Detection of G0 in Live Cells by Hoechst 33342 and Pyronin Y Staining by Eddaoudi, Ayad, Canning, Stephanie Louise, Kato, Itaru

    “…Hoechst 33342 and Pyronin Y double staining can be used to measure DNA and RNA content in live cells by flow cytometry. Quiescent cells at G0 phase have the…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Temozolomide and etoposide combination for the treatment of relapsed osteosarcoma by Akazawa, Ryo, Umeda, Katsutsugu, Saida, Satoshi, Kato, Itaru, Hiramatsu, Hidefumi, Sakamoto, Akio, Arakawa, Yoshiki, Sumiyoshi, Shinji, Okamoto, Takeshi, Moritake, Hiroshi, Adachi, Souichi, Takita, Junko

    Published in Japanese journal of clinical oncology (01-08-2020)
    “…The prognosis of patients with relapsed osteosarcoma is extremely poor and the optimal treatment remains to be identified. Here, we retrospectively analysed…”
    Get full text
    Journal Article
  10. 10

    Ponatinib in pediatric patients with Philadelphia chromosome-positive leukemia: a retrospective survey of the Japan Children’s Cancer Group by Kodama, Yuichi, Sato, Atsushi, Kato, Keisuke, Sakaguchi, Hirotoshi, Kato, Motohiro, Kawasaki, Hirohide, Hiramatsu, Hidefumi, Kato, Itaru, Taga, Takashi, Shimada, Hiroyuki

    Published in International journal of hematology (01-07-2022)
    “…Ponatinib is effective in adults with Philadelphia chromosome-positive (Ph+) leukemia, resistant or intolerant to second-generation tyrosine kinase inhibitors,…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors by Niwa, Akira, Heike, Toshio, Umeda, Katsutsugu, Oshima, Koichi, Kato, Itaru, Sakai, Hiromi, Suemori, Hirofumi, Nakahata, Tatsutoshi, Saito, Megumu K

    Published in PloS one (27-07-2011)
    “…Elucidating the in vitro differentiation of human embryonic stem (ES) and induced pluripotent stem (iPS) cells is important for understanding both normal and…”
    Get full text
    Journal Article
  16. 16

    The first Japanese biobank of patient‐derived pediatric acute lymphoblastic leukemia xenograft models by Tanaka, Kuniaki, Kato, Itaru, Dobashi, Yuu, Imai, Jun‐ichi, Mikami, Takashi, Kubota, Hirohito, Ueno, Hiroo, Ito, Mamoru, Ogawa, Seishi, Nakahata, Tatsutoshi, Takita, Junko, Toyoda, Hidemi, Ogawa, Chitose, Adachi, Souichi, Watanabe, Shinya, Goto, Hiroaki

    Published in Cancer science (01-11-2022)
    “…A lack of practical resources in Japan has limited preclinical discovery and testing of therapies for pediatric relapsed and refractory acute lymphoblastic…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    PAX5 alterations in an infant case of KMT2A‐rearranged leukemia with lineage switch by Nakajima, Koji, Kubota, Hirohito, Kato, Itaru, Isobe, Kiyotaka, Ueno, Hiroo, Kozuki, Kagehiro, Tanaka, Kuniaki, Kawabata, Naoko, Mikami, Takashi, Tamefusa, Kosuke, Nishiuchi, Ritsuo, Saida, Satoshi, Umeda, Katsutsugu, Hiramatsu, Hidefumi, Adachi, Souichi, Takita, Junko

    Published in Cancer science (01-07-2022)
    “…Lineage switch is a rare event at leukemic relapse. While mostly known to occur in KMT2A‐rearranged infant leukemia, the underlying mechanism is yet to be…”
    Get full text
    Journal Article
  20. 20